{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:10:56Z","timestamp":1762506656381,"version":"3.41.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/md.0000000000001702","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T12:48:26Z","timestamp":1445690906000},"page":"e1702","source":"Crossref","is-referenced-by-count":56,"title":["Analysis of the Fibrinogen and Neutrophil\u2013Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"94","author":[{"given":"Takaaki","family":"Arigami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Uchikado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Uenosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Owaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kurahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiya","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Natsugoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-29-20210309","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2188\/jea.JE20120162","article-title":"Epidemiology of esophageal cancer in Japan and China.","volume":"23","author":"Lin","year":"2013","journal-title":"J Epidemiol"},{"key":"R2-29-20210309","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jjco\/hyn064","article-title":"Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001.","volume":"38","author":"Shibata","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"R3-29-20210309","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/SLA.0b013e31827017fc","article-title":"The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients.","volume":"257","author":"Akutsu","year":"2013","journal-title":"Ann Surg"},{"key":"R4-29-20210309","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/1097-0142(20001015)89:8<1677::AID-CNCR5>3.0.CO;2-9","article-title":"Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.","volume":"89","author":"Shimada","year":"2000","journal-title":"Cancer"},{"key":"R5-29-20210309","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R6-29-20210309","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjc.6602922","article-title":"Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.","volume":"94","author":"Al Murri","year":"2006","journal-title":"Br J Cancer"},{"key":"R7-29-20210309","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/SLA.0b013e3181454171","article-title":"Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.","volume":"246","author":"Ishizuka","year":"2007","journal-title":"Ann Surg"},{"key":"R8-29-20210309","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1245\/s10434-010-1383-7","article-title":"Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer.","volume":"18","author":"Vashist","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R9-29-20210309","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/bjc.2012.262","article-title":"Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.","volume":"107","author":"Jiang","year":"2012","journal-title":"Br J Cancer"},{"key":"R10-29-20210309","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/s10434-013-3292-z","article-title":"Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.","volume":"21","author":"Wu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R11-29-20210309","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00535-013-0855-5","article-title":"Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer.","volume":"49","author":"Hirashima","year":"2014","journal-title":"J Gastroenterol"},{"key":"R12-29-20210309","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1245\/s10434-013-3342-6","article-title":"The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.","volume":"21","author":"Nakagawa","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R13-29-20210309","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1440-1746.2006.04736.x","article-title":"Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus.","volume":"22","author":"Takeuchi","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R14-29-20210309","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.5754\/hge11133","article-title":"Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer.","volume":"58","author":"Lu","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"R15-29-20210309","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1447-0756.2011.01780.x","article-title":"Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.","volume":"38","author":"Qiu","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"R16-29-20210309","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10120-013-0330-2","article-title":"Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer.","volume":"17","author":"Cho","year":"2014","journal-title":"Gastric Cancer"},{"key":"R17-29-20210309","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.tranon.2014.07.009","article-title":"The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma.","volume":"7","author":"Feng","year":"2014","journal-title":"Transl Oncol"},{"key":"R18-29-20210309","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ejca.2014.02.015","article-title":"Neutrophillymphocyte ratio as a prognostic factor in biliary tract cancer.","volume":"50","author":"McNamara","year":"2014","journal-title":"Eur J Cancer"},{"key":"R20-29-20210309","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin.","volume":"70","author":"Weisel","year":"2005","journal-title":"Adv Protein Chem"},{"key":"R21-29-20210309","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0031-6997(24)01359-0","article-title":"Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins.","volume":"50","author":"Aplin","year":"1998","journal-title":"Pharmacol Rev"},{"key":"R22-29-20210309","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.2001.tb03525.x","article-title":"Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein.","volume":"936","author":"Simpson-Haidaris","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R23-29-20210309","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/jjco\/28.12.740","article-title":"Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients.","volume":"28","author":"Yamaguchi","year":"1998","journal-title":"Jpn J Clin Oncol"},{"key":"R24-29-20210309","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1538-7836.2007.02808.x","article-title":"Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2).","volume":"6","author":"Sahni","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R25-29-20210309","first-page":"539","article-title":"Inflammation and cancer: back to Virchow L","volume":"357","author":"Balkwill","year":"2001","journal-title":"ancet"},{"key":"R26-29-20210309","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1091-255X(03)00111-2","article-title":"Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in mice.","volume":"7","author":"Pera","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"R27-29-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/02841869509093641","article-title":"Significance of increased neutrophils in patients with advanced colorectal cancer.","volume":"34","author":"Satomi","year":"1995","journal-title":"Acta Oncol"},{"key":"R28-29-20210309","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjc.2011.100","article-title":"Neutrophillymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.","volume":"104","author":"Chua","year":"2011","journal-title":"Br J Cancer"},{"key":"R29-29-20210309","doi-asserted-by":"crossref","first-page":"O90","DOI":"10.1111\/codi.12467","article-title":"Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.","volume":"16","author":"Toh","year":"2014","journal-title":"Colorectal Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T03:45:07Z","timestamp":1748663107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201510030-00029"}},"subtitle":["A Promising Blood Marker of Tumor Progression and Prognosis"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":28,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001702","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}